Treatment of Cocaine Dependence With Lisdexamfetamine

Completed · Phase 2 · Has a placebo group

Conditions studied: Cocaine Dependence

In brief

This protocol is a 2-group double-blind placebo-controlled outpatient study investigating lisdexamfetamine for treatment of cocaine dependence. The investigators plan to enroll 100 subjects in a 14-week trial. The primary objectives will determine changes in cocaine use and secondary objectives will be cocaine craving and impulsivity.

Key facts

Study ID
NCT00958282
Run by
University of Minnesota
People needed
43
Starts
2009-07-01
Expected to finish
2013-01-01
Last updated by the study team
2015-09-17

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.